Objective Organ damage is a key determinant of poor prognosis and increased mortality in systemic lupus erythematosus (SLE).

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

This important study used five metrics to compare the cost-effectiveness of intramural and extramural research funded by the National Institutes of Health in the United States between 2009 and 2019.